SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's Laboratories tumbles on reporting 36% fall in Q1 consolidated net profit

28 Jul 2021 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 4706.35, down by 138.00 points or 2.85% from its previous closing of Rs. 4844.35 on the BSE.

The scrip opened at Rs. 4855.00 and has touched a high and low of Rs. 4875.85 and Rs. 4666.95 respectively. So far 1.28 lakh shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5,613.65 on 07-Jul-2021 and a 52 week low of Rs. 4,019.65 on 28-Jul-2020.

Last one week high and low of the scrip stood at Rs. 5445.05 and Rs. 4666.95 respectively. The current market cap of the company is Rs. 88282.25 crore.

The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.93% and 17.06% respectively.

Dr. Reddy's Laboratories has reported a fall of 56.49% in its net profit at Rs 413.40 crore for the quarter ended June 30, 2021 as compared to Rs 950.20 crore for the same quarter in the previous year. Total income of the company decreased by 6.93% at Rs 3619.70 crore for Q1FY22 as compared Rs 3889.10 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 36.02% in its net profit of associate at Rs 380.40 crore for the quarter ended June 30, 2021 as compared to Rs 594.60 crore for the same quarter in the previous year. However, total income of the company increased by 11.95% at Rs 5053.00 crore for Q1FY22 as compared Rs 4513.60 crore for the corresponding quarter previous year.

Dr. Reddys Lab Share Price

1279.70 -13.55 (-1.05%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×